Prepare for More Insulin Biosimilars

January 2023

Kirsty (insulin aspart) and Semglee (insulin glargine 100 units/mL) will be the latest biosimilars to hit your pharmacy fridges.

Kirsty is a “rapid-acting,” or mealtime, insulin...it will compete with Trurapi as the latest biosimilar to NovoRapid.

These are similar to other rapid-acting mealtime insulins...Apidra (glulisine), Humalog (lispro), etc.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Nebulizers Prevent Errors With Nebulizer Solution Rxs
Insulin Prepare for More Insulin Biosimilars
Practice Don’t Wait to Start Networking
Pediatrics Anticipate More Antidepressant Rxs for Kids
Diabetes Watch for Kerendia, a New Med for Diabetic Kidney Disease
Med Histories Think of Med Indications as a Safeguard
Med Safety Improve Safety With Antiseizure Meds
Constipation Look Out for Common Errors With Constipation Meds
Oral Health Listen for Questions About Med Changes Before Dental Visits